Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.
Bioconjug Chem
; 26(5): 919-31, 2015 May 20.
Article
in En
| MEDLINE
| ID: mdl-25915780
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Stomach Neoplasms
/
Camptothecin
/
Cell Adhesion Molecules
/
Immunoconjugates
/
Antibodies, Monoclonal, Humanized
/
Antibodies, Monoclonal
/
Antigens, Neoplasm
Language:
En
Journal:
Bioconjug Chem
Journal subject:
BIOQUIMICA
Year:
2015
Type:
Article
Affiliation country:
United States